Open-label, Randomized Comparative Clinical Trial on the Clinical Effect of App-based Education Program in Patients With Chronic Kidney Disease
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 129
- 试验地点
- 1
- 主要终点
- Quality of Life (SF-36v2)
研究概览
简要总结
A randomized control trial to test the effect of a mobile app-based educational program for Chronic Kidney Disease patients.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Supportive Care
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 100 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnosed with CKD Stage 1~5
- •Have been receiving CKD treatment for more than 6 months
- •Owns an android mobile phone
排除标准
- •Diagnosed with cancer within 5 years of recruitment
研究组 & 干预措施
Control
Usual care, with no guide on app use. Surveys are administered via Short Message Services links.
Education
Enrolled in a mobile app-based education program, with guidance from a healthcare professional. All educational materials and surveys are provided via the app.
干预措施: Education (Other)
结局指标
主要结局
Quality of Life (SF-36v2)
时间窗: 48 days
36-Item Short Form Health Survey, version 2. Scores range from 0 to 100, higher value corresponding to better outcome (better quality of life)
Potassium
时间窗: 56 days
Serum potassium levels obtained from routine blood test.
Phosphate
时间窗: 56 days
Serum phosphate levels obtained from routine blood test.
MIS
时间窗: 55 days
10-item nutritional status measured with Malnutrition Inflammation Score. Scores range from 0 to 30, higher value corresponding to worse outcome (higher risk of malnutrition)
Albumin
时间窗: 56 days
Serum albumin levels obtained from routine blood test.
次要结局
- Depression(55 days)
- Sodium intake behavior(0 days)
- Insomnia(48 days)
- Creatinine(56 days)
- Sodium intake attitude(0 days)